FRESENIUS KABI USA LLC

Generic and Biosimilar pharmaceutical manufacturer

Three Corporate Drive Lake Zurich IL 60047, Lake Zurich, IL  ·  SARAH D'ORSIE

Filings
31
Clients
1
Total Income
Years Active
2019–2026

Filings

Year Client Period Income Expenses Doc
2026 FRESENIUS KABI USA LLC 1st Quarter (Jan 1 - Mar 31)
AMENDED
$1,100,000
2026 FRESENIUS KABI USA LLC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$1,070,000
2025 FRESENIUS KABI USA LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$430,000
2025 FRESENIUS KABI USA LLC 3rd Quarter (July 1 - Sep 30)
AMENDED
$340,000
2025 FRESENIUS KABI USA LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$320,000
2025 FRESENIUS KABI USA LLC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$75,000
2025 FRESENIUS KABI USA LLC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$712,941
2024 FRESENIUS KABI USA LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$75,000
2024 FRESENIUS KABI USA LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$75,000
2024 FRESENIUS KABI USA LLC 2nd Quarter (Apr 1 - June 30)
AMENDED
$75,000
Page 1 of 4  ·  31 filings Next

Clients Represented

ClientFilingsTotal Income
FRESENIUS KABI USA LLC 31

Lobbyists

NameDisclosed Prior Position
CRAIG BURTON
TIMOTHY CASEY Office of Senator Tom Carper (D-DE) Office of Congressman John Tierney (D-MA)
SARAH CHRISTINE D'ORSIE Office of Congressman Tom Davis (R-VA), Professional Staff, House Government Reform and Oversight Committee
STU EVENHAUGEN Dir. of Pol. Analysis & Evaluation, Off. of the Assist. Sec. of Defense for Health Affairs; Strategy & Pol. Analyst, US…
CHRISTOPHER LEIBUNDGUTH N/A
STEVEN CHASE WALKER Congressman Jodey Arrington